A model for malignancy-associated humoral hypercalcemia.
Tumor tissue from a patient with squamous cell carcinoma of the lung and hypercalcemia has been serially implanted into athymic mice. Tumor-bearing mice develop cachexia, hypercalcemia without bone metastases, hypophosphatemia, increased urinary cyclic adenosine monophosphate (cAMP) to creatinine ratio, and undetectable human immunoreactive parathyroid hormone levels. Radiographs of spines in the tumor-bearing mice demonstrate demineralization, suggesting skeletal resorption as the source of the hypercalcemia. Within 4-8 hours following tumor removal, hypercalcemia is reversed, suggesting that a relatively short-acting humoral substance is responsible for the hypercalcemia. The animals gain weight and become essentially normal within 4 days following tumor removal. The studies demonstrate that this animal model is similar in many aspects to human malignancy-associated humoral hypercalcemia (MAHH) and can provide a useful tool for further investigation of the pathogenesis and treatment of this syndrome.
D000818:Animals; D002118:Calcium / Q000097:blood; D002294:Carcinoma, Squamous Cell / Q000150:complications* / Q000473:pathology; D004195:Disease Models, Animal; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology* / Q000503:physiopathology; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D008875:Middle Aged; D008903:Minerals / Q000378:metabolism; D009368:Neoplasm Transplantation; D010758:Phosphorus / Q000097:blood; D013131:Spine / Q000378:metabolism
D008903:Minerals; D010758:Phosphorus; D002118:Calcium